Analysts forecast that LHC Group, Inc. (NASDAQ:LHCG) will post $283.31 million in sales for the current fiscal quarter, according to Zacks. Five analysts have provided estimates for LHC Group’s earnings. The lowest sales estimate is $278.30 million and the highest is $288.20 million. LHC Group reported sales of $235.44 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 20.3%. The firm is scheduled to announce its next quarterly earnings results on Wednesday, March 14th.
On average, analysts expect that LHC Group will report full year sales of $283.31 million for the current financial year, with estimates ranging from $1.06 billion to $1.07 billion. For the next fiscal year, analysts forecast that the company will post sales of $1.18 billion per share, with estimates ranging from $1.15 billion to $1.20 billion. Zacks’ sales calculations are an average based on a survey of sell-side research analysts that cover LHC Group.
A number of equities research analysts recently issued reports on the company. BidaskClub upgraded LHC Group from a “strong sell” rating to a “sell” rating in a research report on Wednesday, February 7th. Zacks Investment Research upgraded LHC Group from a “sell” rating to a “hold” rating in a research report on Wednesday, January 31st. Robert W. Baird reiterated a “hold” rating and issued a $69.00 price objective on shares of LHC Group in a research report on Friday, November 10th. Royal Bank of Canada increased their price objective on LHC Group from $70.00 to $81.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 7th. Finally, Oppenheimer increased their price objective on LHC Group from $68.00 to $80.00 and gave the stock an “outperform” rating in a research report on Tuesday, November 7th. One analyst has rated the stock with a sell rating, three have issued a hold rating and nine have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $77.10.
Shares of LHC Group (NASDAQ LHCG) traded down $0.06 during mid-day trading on Friday, hitting $63.50. The company had a trading volume of 190,600 shares, compared to its average volume of 276,288. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24. LHC Group has a one year low of $46.24 and a one year high of $76.14. The stock has a market capitalization of $1,161.81, a P/E ratio of 27.28, a PEG ratio of 1.70 and a beta of 0.71.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. The Manufacturers Life Insurance Company raised its position in LHC Group by 3.1% during the second quarter. The Manufacturers Life Insurance Company now owns 12,254 shares of the health services provider’s stock valued at $832,000 after purchasing an additional 372 shares in the last quarter. Thrivent Financial For Lutherans raised its position in LHC Group by 8.6% during the second quarter. Thrivent Financial For Lutherans now owns 9,100 shares of the health services provider’s stock valued at $618,000 after purchasing an additional 720 shares in the last quarter. American International Group Inc. raised its position in LHC Group by 7.2% during the third quarter. American International Group Inc. now owns 12,533 shares of the health services provider’s stock valued at $889,000 after purchasing an additional 840 shares in the last quarter. Wedge Capital Management L L P NC raised its position in LHC Group by 15.9% during the third quarter. Wedge Capital Management L L P NC now owns 7,527 shares of the health services provider’s stock valued at $534,000 after purchasing an additional 1,035 shares in the last quarter. Finally, OppenheimerFunds Inc. increased its holdings in shares of LHC Group by 10.4% in the fourth quarter. OppenheimerFunds Inc. now owns 11,388 shares of the health services provider’s stock worth $698,000 after buying an additional 1,071 shares during the period. Institutional investors and hedge funds own 84.63% of the company’s stock.
WARNING: “LHC Group, Inc. (LHCG) Expected to Announce Quarterly Sales of $283.31 Million” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another website, it was illegally copied and republished in violation of U.S. and international copyright law. The original version of this report can be accessed at https://www.dispatchtribunal.com/2018/02/13/lhc-group-inc-lhcg-expected-to-announce-quarterly-sales-of-283-31-million.html.
About LHC Group
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Get a free copy of the Zacks research report on LHC Group (LHCG)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.